Metoclopramide Export Market Intelligence: India's 321 Suppliers Shipping to 126 Countries — TransData Nexus 2026

Q: Who are the top metoclopramide exporters from India?

The top metoclopramide exporters from India are: 1. IPCA LABORATORIES LIMITED — $10.9M (48.1% market share); 2. AVET LIFESCIENCES PRIVATE LIMITED — $2.9M (12.6% market share); 3. BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED — $947.6K (4.2% market share); 4. MAAN PHARMACEUTICALS LTD — $918.0K (4.0% market share); 5. LINCOLN PHARMACEUTICALS LTD — $887.8K (3.9% market share). Together they account for 72.9% of India's total metoclopramide export value.

Q: What is the total export value of metoclopramide from India?

The total export value of metoclopramide from India is $22.7M USD, recorded across 2,053 shipment transactions from 321 active exporters to 126 destination countries. The average shipment value is $11.1K.

Q: Which countries import metoclopramide from India?

India exports metoclopramide to 126 countries worldwide. The top importing countries are: FINLAND (28.5% share, $6.5M), UNITED STATES (19.3% share, $4.4M), AUSTRALIA (13.2% share, $3.0M), CANADA (7.0% share, $1.6M), MYANMAR (4.5% share, $1.0M). These five markets account for 72.4% of total export value.

Q: What is the average price of metoclopramide exports from India?

The average unit price for metoclopramide exports from India is $14.22 USD per unit, with prices ranging from $0.00 to $12052.10 depending on formulation, packaging, and order volume. The total market is valued at $22.7M across 2,053 shipments.

Q: Which ports handle metoclopramide exports from India?

The primary ports for metoclopramide exports from India are NHAVA SHEVA SEA (INNSA1) (12.9% of shipments), SAHAR AIR (10.9% of shipments), SAHAR AIR CARGO ACC (INBOM4) (9.7% of shipments), DELHI AIR CARGO ACC (INDEL4) (7.2% of shipments), JNPT/ NHAVA SHEVA SEA (5.8% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of metoclopramide?

India is one of the world's leading exporters of metoclopramide due to its large base of 321 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports metoclopramide to 126 countries, demonstrating 65% global market coverage.

Q: What certifications do Indian metoclopramide exporters need?

Indian metoclopramide exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import metoclopramide from India?

There are 568 registered buyers importing metoclopramide from India, spread across 126 countries. The repeat buyer rate is 51.4%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top metoclopramide supplier from India?

IPCA LABORATORIES LIMITED is the leading metoclopramide exporter from India with a market share of 48.1% and total export value of $10.9M across 102 shipments. The top 5 suppliers together control 72.9% of total export value.

Suresh Sormare

Metoclopramide

India Pharmaceutical Trade Intelligence

$22.7M321 Suppliers126 CountriesHS 30049035

ExportsIndia → FINLAND28.5%India → UNITED STATES19.3%

ImportsCHINA → India$4.6K UNITED STATES → India$3.7K

#1 Supplier: IPCA LABORATORIES #1 Buyer: AVET PHARMACEUTICALS

Metoclopramide Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Metoclopramide to the World

Between 2022 and 2026, India exported $22.7M worth of metoclopramide across 2,053 verified shipments to 126 countries — covering 65% of world markets in the Gastrointestinal segment. The largest destination is FINLAND (28.5%). IPCA LABORATORIES LIMITED leads with a 48.1% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Metoclopramide export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Metoclopramide export data snapshot — $22.7M · 321 exporters · 126 countriesTransData Nexus · Indian Customs Data

Top Metoclopramide Exporters from India

321 active exporters · Ranked by export value

View all 321 →

Top Metoclopramide Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	IPCA LABORATORIES LIMITED	$10.9M	102	8	48.1%
2	AVET LIFESCIENCES PRIVATE LIMITED

Top Countries Importing Metoclopramide from India

126 destination markets · Ranked by import value

All 126 countries →

Top Countries Importing Metoclopramide from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	FINLAND	$6.5M	28.5%
2	UNITED STATES	$4.4M	19.3%
3	AUSTRALIA	$3.0M	13.2%
4	CANADA	$1.6M	7.0%
5	MYANMAR	$1.0M	4.5%
6	SOUTH AFRICA	$1.0M	4.4%
7	TANZANIA	$962.1K	4.2%
8	IRAQ	$446.2K	2.0%
9	ETHIOPIA	$311.5K	1.4%
10	DENMARK	$249.3K	1.1%

FINLAND is India's largest metoclopramide export destination, absorbing 28.5% of total exports worth $6.5M. The top 5 importing countries — FINLAND, UNITED STATES, AUSTRALIA, CANADA, MYANMAR — together account for 72.4% of India's total metoclopramide export value. The remaining 121 destination countries collectively receive the other 27.6%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Metoclopramide to India?

8 origin countries · Total import value: $9.6K

India imports metoclopramide from 8 countries with a combined import value of $9.6K. The largest supplier is CHINA ($4.6K, 1 shipments), followed by UNITED STATES and GERMANY. All values are from Indian Customs (DGFT) import records.

Countries Supplying Metoclopramide to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	CHINA	$4.6K	1	47.7%
2	UNITED STATES	$3.7K	12	37.9%
3	GERMANY	$1.2K	5	12.0%
4	SOUTH AFRICA	$104	7	1.1%
5	SWITZERLAND	$98	2	1.0%
6	UNITED KINGDOM	$26	3	0.3%
7	AUSTRALIA	$1	1	0.0%
8	GAMBIA	$0	1	0.0%

CHINA is the largest supplier of metoclopramide to India, accounting for 47.7% of total import value. The top 5 origin countries — CHINA, UNITED STATES, GERMANY, SOUTH AFRICA, SWITZERLAND — together supply 99.7% of India's metoclopramide imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Metoclopramide

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

Metoclopramide has been a staple in the U.S. pharmaceutical market for several decades, with numerous Abbreviated New Drug Applications (ANDAs) approved by the FDA. A notable approval includes UDL Laboratories, Inc.'s metoclopramide oral solution (ANDA 75-051) on January 26, 2001. More recently, on September 4, 2009, Wilmington Pharmaceuticals received approval for Metozolv ODT (metoclopramide hydrochloride) orally disintegrating tablets (NDA 022246). Additionally, on September 16, 2009, ANI Pharmaceuticals Inc. obtained approval for metoclopramide oral solution USP, 5 mg/5 mL (ANDA 71-402/S-008).

The regulatory pathway for metoclopramide in the U.S. involves the submission of an ANDA, demonstrating bioequivalence to the reference listed drug. Given the established market presence and multiple approvals, Indian exporters aiming to enter the U.S. market must ensure strict compliance with FDA regulations, including adherence to current Good Manufacturing Practices (cGMP) and thorough documentation of bioequivalence studies. The presence of 321 active Indian exporters underscores the competitive landscape, necessitating a robust regulatory strategy for market entry.

2EU & UK Regulatory Framework

In the European Union, metoclopramide-containing medicines have been subject to regulatory scrutiny to ensure patient safety. In October 2013, the European Medicines Agency (EMA) recommended changes to the use of metoclopramide, including restricting the dose and duration to minimize the risk of neurological side effects. (ema.europa.eu) These recommendations were confirmed in December 2013. (ema.europa.eu) Manufacturers must comply with EU Good Manufacturing Practice (GMP) guidelines, which encompass quality management, personnel, premises, equipment, documentation, production, quality control, and self-inspection. In the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) oversees the marketing authorization of medicinal products, ensuring they meet safety, quality, and efficacy standards.

3WHO Essential Medicines & Global Standards

Metoclopramide is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its importance in a basic health system. The drug is also listed in major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring standardized quality and formulation across different regions.

4India Regulatory Classification

In India, metoclopramide is classified under Schedule H of the Drugs and Cosmetics Rules, indicating that it is a prescription drug and should be dispensed only on the prescription of a registered medical practitioner. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines; however, as of the latest available data, metoclopramide is not listed under the Drugs (Prices Control) Order (DPCO), implying no ceiling price is currently imposed. For export purposes, manufacturers must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT), ensuring compliance with export regulations.

5Patent & Exclusivity Status

Metoclopramide's primary patents have long expired, leading to a competitive generic market. This expiration has facilitated the entry of multiple generic manufacturers, including Indian exporters, into both domestic and international markets.

6Recent Industry Developments

In December 2025, the European Medicines Agency (EMA) recommended updates to the product information for metoclopramide-containing medicines to include visual disturbances and oculogyric crisis as potential adverse effects. (ema.europa.eu) This underscores the importance of continuous pharmacovigilance and the need for manufacturers to update safety information accordingly.

In January 2026, the U.S. FDA issued a tentative approval for Teva Pharmaceuticals' metoclopramide nasal spray (ANDA 216931), indicating that the product meets the necessary requirements but cannot be marketed until patent or exclusivity issues are resolved. This development highlights ongoing innovation in drug delivery methods for metoclopramide.

These developments reflect the dynamic regulatory environment surrounding metoclopramide, emphasizing the need for exporters to stay informed and compliant with evolving standards and requirements.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Metoclopramide

Retail & reference prices across 9 markets vs. India FOB export price of $14.22/unit

Global Price Benchmark for Metoclopramide across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.10	USD	According to the FDA Orange Book, metoclopramide is an approved generic medication, contributing to its affordability in the U.S. market.
United Kingdom	$0.11	GBP	The NHS Drug Tariff lists metoclopramide as a standard treatment, ensuring its availability at regulated prices within the UK healthcare system.
Germany	$0.10	EUR	The European Medicines Agency (EMA) includes metoclopramide in its list of approved medicines, facilitating its widespread use across EU member states.
Australia

Supply Chain Risk Assessment — Metoclopramide

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry heavily relies on China for Key Starting Materials (KSMs), the essential chemical precursors for Active Pharmaceutical Ingredients (APIs). Approximately 41% of KSMs used in U.S.-approved APIs are solely sourced from China, while 16% come exclusively from India. This dependency poses significant risks, as any disruption in China's supply chain can directly impact India's API production capabilities.

Recent events have highlighted this vulnerability. In February 2026, the closure of the Strait of Hormuz due to geopolitical tensions led to a sharp decline in maritime transit, affecting global energy supplies and causing oil prices to surge. Such disruptions can have cascading effects on the availability and cost of raw materials necessary for API production.

2Supplier Concentration & Single-Source Risk

The export market for Metoclopramide from India is notably concentrated. The top five exporters account for 72.9% of the total export value, with IPCA Laboratories Limited alone contributing 48.1% ($10.9 million USD). This high concentration increases the risk of supply chain disruptions if any of these key suppliers face operational challenges.

To mitigate such risks, the Indian government has implemented the Production Linked Incentive (PLI) scheme, aiming to boost domestic production of critical APIs and reduce reliance on imports. In November 2024, two greenfield plants were inaugurated under this scheme to manufacture essential molecules like Penicillin G and 6-APA, marking a significant step towards self-sufficiency.

Access Complete Metoclopramide Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 2,053 transactions across 126 markets.

Request Demo View Pricing

Frequently Asked Questions — Metoclopramide Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top metoclopramide exporters from India?

The leading metoclopramide exporters from India are IPCA LABORATORIES LIMITED, AVET LIFESCIENCES PRIVATE LIMITED, BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED, and 10 others. IPCA LABORATORIES LIMITED leads with 48.1% market share ($10.9M). The top 5 suppliers together control 72.9% of total export value.

What is the total export value of metoclopramide from India?

The total export value of metoclopramide from India is $22.7M, recorded across 2,053 shipments from 321 active exporters to 126 countries. The average shipment value is $11.1K.

Which countries import metoclopramide from India?

India exports metoclopramide to 126 countries. The top importing countries are FINLAND (28.5%), UNITED STATES (19.3%), AUSTRALIA (13.2%), CANADA (7.0%), MYANMAR (4.5%), which together account for 72.4% of total export value.

What is the HS code for metoclopramide exports from India?

The primary HS code for metoclopramide exports from India is 30049035. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Metoclopramide

Metoclopramide

Top Metoclopramide Exporters from India

Top Countries Importing Metoclopramide from India

Who Supplies Metoclopramide to India?

Quick Facts

Related Gastrointestinal

Related Analysis

Need Details?

Regulatory Landscape — Metoclopramide

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Metoclopramide

Supply Chain Risk Assessment — Metoclopramide

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Metoclopramide Trade Intelligence

Frequently Asked Questions — Metoclopramide Exports from India

Who are the top metoclopramide exporters from India?

What is the total export value of metoclopramide from India?

Which countries import metoclopramide from India?

What is the HS code for metoclopramide exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of metoclopramide exports from India?

Which ports handle metoclopramide exports from India?

Why is India a leading exporter of metoclopramide?

What certifications do Indian metoclopramide exporters need?

How many buyers import metoclopramide from India?

What is the market share of the top metoclopramide exporter from India?

Analysis Methodology